Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Total Debt (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Total Debt for 16 consecutive years, with $750000.0 as the latest value for Q4 2025.

  • Quarterly Total Debt fell 77.22% to $750000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $750000.0 through Dec 2025, down 77.22% year-over-year, with the annual reading at $750000.0 for FY2025, 77.22% down from the prior year.
  • Total Debt for Q4 2025 was $750000.0 at Plus Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Total Debt was $6.8 million in Q3 2021, with the low at $750000.0 in Q4 2025.
  • Average Total Debt over 5 years is $4.7 million, with a median of $4.9 million recorded in 2023.
  • The sharpest move saw Total Debt grew 9.82% in 2021, then tumbled 77.22% in 2025.
  • Over 5 years, Total Debt stood at $6.8 million in 2021, then dropped by 20.11% to $5.4 million in 2022, then fell by 26.29% to $4.0 million in 2023, then dropped by 17.2% to $3.3 million in 2024, then crashed by 77.22% to $750000.0 in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $750000.0, $3.3 million, and $3.3 million for Q4 2025, Q4 2024, and Q3 2024 respectively.